Saud H. AlDubayan

Broad Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index4.1kcitations115works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(53), Genetic factors in colorectal cancer(32), Prostate Cancer Treatment and Research(25), Cancer Immunotherapy and Biomarkers(12), Colorectal Cancer Treatments and Studies(9)

Publications115 total

Simulation and empirical evaluation of biologically-informed neural network performance
Machine Learning with Applications·2026Open Access
Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2025Open Access
Supplementary Table S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2025Open Access
Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2025Open Access
Simulation and empirical evaluation of biologically-informed neural network performance
2025Open Access
Genomic correlates of clinical CAR-T cell activity
2025Open Access
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
Nature Communications·2025· 9 citedOpen Access
Rare germline structural variants increase risk for pediatric solid tumors
Science·2025· 14 citedOpen Access
Whole exome correlates in metastatic hormone sensitive prostate cancer (mHSPC): Results from E3805 CHAARTED.
Journal of Clinical Oncology·2024· 1 cited
Abstract PO2-27-12: Genomic determinants of benefit to nivolumab (NIVO) plus low dose ipilimumab (IPI) among patients (pts) with hypermutated HER2-negative metastatic breast cancer (MBC): results of NIMBUS trial
Cancer Research·2024
Rare germline structural variants increase risk for pediatric solid tumors
2024· 1 citedOpen Access
Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma
European Urology Open Science·2024· 7 citedOpen Access
Abstract P01: Impact of Germline and Somatic <i>ATM</i> Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition
Blood Cancer Discovery·2024
Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa–Associated Cutaneous Squamous Cell Carcinoma
Journal of Investigative Dermatology·2024· 2 citedOpen Access
Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients
Genome Medicine·2023· 3 citedOpen Access
Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023Open Access
Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023Open Access
Supplementary Table S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023Open Access
Supplementary Table S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023Open Access
Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Eliezer M. Van Allen(35), Brendan Reardon(11), Sabrina Y. Camp(11), Jihye Park(10), David Liu(7), Amaro Taylor‐Weiner(7), Meng Xiao He(7), Jake R. Conway(7), Mary‐Ellen Taplin(6), Jett Crowdis(6), Eric Kofman(6), Amein K. Al‐Ali(6), Hoyin Chu(6), Haitham Elmarakeby(5), Gad Getz(5), Nathanael D. Moore(5), Nicholas Moore(5), Seunghun Han(5), Riaz Gillani(5), Alexander T. M. Cheung(5)